Ceftazidime is the antipseudomonal cephalosporin MoH tender desks specify by name for febrile neutropenia and hospital-acquired pneumonia, and M Care Exports sources both Fortaz/Fortum and the licensed generic against a confirmed purchase order.
M Care Exports supplies ceftazidime, marketed historically as Fortaz (US) and Fortum (Gulf and much of Africa), alongside licensed generic ceftazidime for injection. We are a merchant exporter, not a manufacturer: we route each tender line through the dossier and quality chain the buyer's market and formulary specify, brand or generic.
Ceftazidime exporter and bulk supplier from India.
For MoH antimicrobial tenders, febrile-neutropenia protocols and burns-unit formularies specifying ceftazidime, M Care sources both the originator and generic 500mg, 1g and 2g injection vials against confirmed purchase orders. Generic volumes route through WHO-GMP manufacturing partner lines; originator stock moves through licensed Indian distribution channels. This is an antipseudomonal Watch-group antibiotic with no long shelf-life buffer once reconstituted, so lot-level cold-chain and expiry planning matter more than for oral generics.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Third-generation cephalosporin (antipseudomonal), sourced and documented for export.
Ceftazidime is a third-generation cephalosporin with reliable activity against Pseudomonas aeruginosa, a coverage gap most other third-generation cephalosporins do not fill. It works by inhibiting bacterial cell-wall synthesis, binding penicillin-binding proteins to block peptidoglycan cross-linking.
Per the FDA label for Fortaz, licensed indications include lower respiratory tract infections, skin and skin-structure infections, urinary tract infections, bacterial septicaemia, bone and joint infections, gynaecologic infections, intra-abdominal infections and bacterial meningitis. The UK SmPC for the licensed generic adds nosocomial pneumonia, cystic-fibrosis broncho-pulmonary infection, chronic suppurative otitis media, complicated urinary tract infection, dialysis-associated peritonitis, febrile neutropenia (empiric therapy) and perioperative prophylaxis for prostate resection to that list.
Supplied as powder for solution for injection or infusion in 500mg, 1g and 2g single-dose vials, reconstituted with Water for Injection or compatible diluent. Labelled storage ceilings vary from 25C to 30C depending on the specific FDA or UK label; reconstituted solution is short-lived and typically needs refrigeration if not used within hours.
Active ingredient
ceftazidime pentahydrate. Third-generation cephalosporin (antipseudomonal).
Forms and strengths
500 mg vial for injection; 1 g vial for injection; 2 g vial for injection.
Indications
A third-generation cephalosporin with reliable Pseudomonas aeruginosa coverage, licensed for lower respiratory tract, skin and soft-tissue, urinary tract, intra-abdominal, bone and joint infections, septicaemia, bacterial meningitis, febrile neutropenia and surgical prophylaxis, per FDA and UK SmPC labelling.
Administration
intravenous, intramuscular. Powder for solution for injection or infusion.
Documentation
Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.
Hospital pharmacies, licensed importers and tender desks across our export markets.
India is our origin. We do not sell into the Indian market.
Buyers for ceftazidime through M Care typically include NHS trust pharmacy buyers and UK hospital wholesalers stocking it for febrile-neutropenia and Pseudomonas cover, GCC MoH tender desks (Saudi Arabia, UAE, Kuwait, Oman) specifying Fortum or WHO-GMP generic ceftazidime for ICU and burns-unit formularies, African MoH procurement units and licensed importers in Nigeria, Kenya and Ghana sourcing broad-spectrum injectable cephalosporins for tertiary hospitals, and NGO and Global Fund-adjacent procurement teams stocking a reliable Pseudomonas-active agent for surgical and trauma settings where local antibiograms call for it.
GCC registration routes
Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.
UK unlicensed routes
Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.
Tender desks
Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.
Dossier support
CTD documentation from the sourcing manufacturer, compiled for your regulator's format.
What the dispensing pharmacist checks on ceftazidime.
Ceftazidime dosing is indication- and site-driven rather than flat: standard adult dosing runs 1g to 2g IV every 8 hours for most serious infections, stepping up to 2g every 8 hours for meningitis or febrile neutropenia, per the FDA and UK SmPC labels. Renal adjustment starts at creatinine clearance below 50 mL/min and steps down through defined bands to 500mg every 48 hours in severe renal impairment, so a current creatinine clearance should travel with every tender order for ICU stock. Reconstituted vials release carbon dioxide and develop positive pressure on dissolution, a known handling quirk worth flagging to ward pharmacy staff drawing up doses. In-use stability of the reconstituted solution varies by labeller: FDA labelling for Fortaz and the generic allows 12 hours at room temperature or up to 3 days refrigerated, while the UK SmPC for the licensed generic states 8 hours at 25C or 24 hours refrigerated, so this is not a product to bulk-reconstitute ahead of a shift; check the labeller's own in-use stability data against the diluent in use. No premedication is required, but as with any beta-lactam, screen for penicillin/cephalosporin cross-reactivity before empiric use in a penicillin-allergic patient.
The documentation pack a regulator actually asks for.
Ceftazidime is Watch-group under the WHO AWaRe antibiotic classification and sits on the WHO Model List of Essential Medicines (complementary list), where its listed use is intravitreal empiric therapy for bacterial endophthalmitis; the broader systemic indications on the FDA and UK labels are a separate, buyer-relevant clinical scope and are not conflated with that EML listing. M Care's CTD/eCTD dossier authoring support covers registration filings where a destination market requires local submission ahead of tender participation.
On brand versus generic: Fortaz (US) and Fortum (Gulf and much of Africa) are the GSK-originated brand names, and M Care supplies both through licensed Indian distribution channels alongside FDA- and MHRA-recognised generic ceftazidime for injection sourced from WHO-GMP manufacturing partner sites. M Care holds no manufacturing licence or WHO-GMP certification of its own and sources against the buyer's specification; tender documents specifying brand-only or INN-only lines should state that requirement on the purchase order. Cold-chain documentation applies to the dry powder within its labelled storage range and, separately, to reconstituted solution where a hospital pharmacy holds stock beyond same-shift use.
Permit sequence, registration status and customs handling are documented in importing medicines from India through the licensed route; this page sticks to what is specific to the molecule.
CoA and MoA, per batch
Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.
CoPP, WHO-GMP, MFG licence
Certificate of pharmaceutical product and site GMP certification issued via CDSCO channels, naming the actual manufacturing site.
CTD Module 3
Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.
Pack insert, labels, artwork
Destination-language patient information and labelling to the local regulator's standard, locked before shipment.
Pharmacovigilance
A named PV contact arranged in the destination market where the registration requires one.
Adjacent lines procurement desks order alongside ceftazidime.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Form and strength, pack preference, destination market and indicative volume for ceftazidime.
- We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
- Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
- Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
- After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Ceftazidime supply, the specific questions.
Is there a generic version of ceftazidime?
Yes. Generic ceftazidime for injection is approved by the FDA and licensed in the UK (Wockhardt UK Ltd holds a current SmPC), alongside the originator brands Fortaz (US) and Fortum (Gulf, much of Africa) from GSK. M Care can source either against a confirmed purchase order; tell us which your tender or formulary specifies.
What is ceftazidime used for?
A third-generation cephalosporin with reliable Pseudomonas aeruginosa coverage, licensed per the FDA label for lower respiratory tract, skin and soft-tissue, urinary tract, intra-abdominal and bone and joint infections, septicaemia and bacterial meningitis. The UK SmPC for the licensed generic adds nosocomial pneumonia, cystic-fibrosis broncho-pulmonary infection and febrile neutropenia.
Does ceftazidime need dose adjustment for renal impairment?
Yes. Dosing steps down at creatinine clearance below 50 mL/min, per the FDA label, through defined bands to as low as 500mg every 48 hours in severe impairment. A current creatinine clearance should accompany any ICU or renal-ward order.
Does ceftazidime injection require cold-chain shipping?
The dry powder is stored below the temperature stated on the labelled pack (25C to 30C depending on labeller) and does not need refrigerated transport in that state. Once reconstituted, the solution has a short in-use life (as little as 8 hours at room temperature on some labels) and is typically kept refrigerated if not used promptly, so ward-level handling matters more than freight cold-chain for this product.
Is ceftazidime on the WHO Essential Medicines List?
Yes, on the complementary list, and it is classified Watch-group under the WHO AWaRe antibiotic framework. Its EML listing covers a specific injectable use for bacterial endophthalmitis; the systemic indications hospitals order it for come from the FDA and UK product labels.
Can M Care supply Fortaz or Fortum to our market?
Yes. M Care sources Fortaz and Fortum through licensed Indian distribution channels of the originator on an import basis; we are a merchant exporter and do not manufacture the product or hold WHO-GMP certification ourselves. Confirm your market's import and registration requirements and we will structure the order accordingly.
Who stands behind this page, and where its statements come from.
Reviewed by Dr. Rajat Bhatt, PharmD, Managing Director, M Care Exports. Last reviewed 2026-09-11.
This page is sourcing information for licensed importers, hospital procurement and tender desks. It is not medical, pharmaceutical or prescribing advice, and it is not a substitute for the approved product information of the line on your order. See our full disclaimer.
Send the specifics. You'll have a price inside one working day.
Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.